Literature DB >> 9353082

Cytokine profile suggesting that murine cerebral malaria is an encephalitis.

V M Jennings1, J K Actor, A A Lal, R L Hunter.   

Abstract

Cerebral malaria (CM) remains a poorly understood and life-threatening complication of malaria caused by the parasite Plasmodium falciparum. The discovery that murine CM caused by Plasmodium berghei ANKA and human CM are both characterized by production of inflammatory cytokines, especially tumor necrosis factor alpha (TNF-alpha), led to a revival of the suggestion that P. berghei CM may have value as a model of the human disease. In this study, quantitative reverse transcription-PCR was used to measure levels of message for 18S rRNA of P. berghei and 10 cytokines in the brains, livers, and spleens of mice during the induction and course of CM. A coordinated increase in RNA of parasite and proinflammatory cytokines was observed in the brains of mice in parallel with onset of CM. Levels of message for parasite, TNF-alpha, and gamma interferon increased in the brains of mice from day 5 to death on day 7. These changes were observed only in the brain, and message for other cytokines remained near baseline levels. This demonstrated that parasite sequestration does take place in the brains of mice with CM. Histologically, CM was characterized by widespread damage to the microvasculature in the brain with focal infiltration of inflammatory cells. The pattern of cytokine production in the brain is characteristic of other murine encephalitides.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9353082      PMCID: PMC175703          DOI: 10.1128/iai.65.11.4883-4887.1997

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  36 in total

1.  Evaluation of electrochemiluminescence- and bioluminescence-based assays for quantitating specific DNA.

Authors:  A M Siddiqi; V M Jennings; M R Kidd; J K Actor; R L Hunter
Journal:  J Clin Lab Anal       Date:  1996       Impact factor: 2.352

2.  Interferon-gamma is essential for the development of cerebral malaria.

Authors:  W Rudin; N Favre; G Bordmann; B Ryffel
Journal:  Eur J Immunol       Date:  1997-04       Impact factor: 5.532

3.  Chadwick lecture. Cerebral malaria--the quest for suitable experimental models in parasitic diseases of man.

Authors:  M Yoeli
Journal:  Trans R Soc Trop Med Hyg       Date:  1976       Impact factor: 2.184

4.  Human brain endothelial cells and astrocytes produce IL-1 beta but not IL-10.

Authors:  E Corsini; A Dufour; E Ciusani; M Gelati; S Frigerio; A Gritti; L Cajola; G L Mancardi; G Massa; A Salmaggi
Journal:  Scand J Immunol       Date:  1996-11       Impact factor: 3.487

5.  Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration.

Authors:  G G MacPherson; M J Warrell; N J White; S Looareesuwan; D A Warrell
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

6.  Cerebral malaria. A disseminated vasculomyelinopathy.

Authors:  G Toro; G Román
Journal:  Arch Neurol       Date:  1978-05

7.  Topographical distribution of the cerebral lesions in mice infected with Plasmodium berghei.

Authors:  T Polder; C Jerusalem; W Eling
Journal:  Tropenmed Parasitol       Date:  1983-12

8.  Splenic requirement for antigenic variation and expression of the variant antigen on the erythrocyte membrane in cloned Plasmodium knowlesi malaria.

Authors:  J W Barnwell; R J Howard; H G Coon; L H Miller
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

9.  Localization of monocyte chemoattractant peptide-1 expression in the central nervous system in experimental autoimmune encephalomyelitis and trauma in the rat.

Authors:  J W Berman; M P Guida; J Warren; J Amat; C F Brosnan
Journal:  J Immunol       Date:  1996-04-15       Impact factor: 5.422

10.  Expression of the inducible isoform of nitric oxide synthase in the central nervous system of mice correlates with the severity of actively induced experimental allergic encephalomyelitis.

Authors:  Y Okuda; Y Nakatsuji; H Fujimura; H Esumi; T Ogura; T Yanagihara; S Sakoda
Journal:  J Neuroimmunol       Date:  1995-10       Impact factor: 3.478

View more
  30 in total

1.  Assessing vascular permeability during experimental cerebral malaria by a radiolabeled monoclonal antibody technique.

Authors:  H C van der Heyde; P Bauer; G Sun; W L Chang; L Yin; J Fuseler; D N Granger
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Expression of Tim-1 and Tim-3 in Plasmodium berghei ANKA infection.

Authors:  Bo Huang; Man Liu; Shiguang Huang; Bin Wu; Hong Guo; Xin-Zhuan Su; Fangli Lu
Journal:  Parasitol Res       Date:  2013-05-08       Impact factor: 2.289

3.  Increased Gal-9 and Tim-3 expressions during liver damage in a murine malarial model.

Authors:  Siyu Xiao; Jinfeng Liu; Shiguang Huang; Fangli Lu
Journal:  Parasitol Res       Date:  2016-02       Impact factor: 2.289

4.  Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition.

Authors:  Catherine J Clark; Gillian M Mackay; George A Smythe; Sonia Bustamante; Trevor W Stone; R Stephen Phillips
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

5.  Association of a determinant on mouse chromosome 18 with experimental severe Plasmodium berghei malaria.

Authors:  Eiji Nagayasu; Koichi Nagakura; Mayumi Akaki; Gen Tamiya; Satoshi Makino; Yamaji Nakano; Minoru Kimura; Masamichi Aikawa
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

6.  Cloned lines of Plasmodium berghei ANKA differ in their abilities to induce experimental cerebral malaria.

Authors:  V Amani; M I Boubou; S Pied; M Marussig; D Walliker; D Mazier; L Rénia
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

7.  Evidence for multiple pathologic and protective mechanisms of murine cerebral malaria.

Authors:  V M Jennings; A A Lal; R L Hunter
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

8.  Electron microscopic features of brain edema in rodent cerebral malaria in relation to glial fibrillary acidic protein expression.

Authors:  Sumate Ampawong; Urai Chaisri; Parnpen Viriyavejakul; Apichart Nontprasert; Georges E Grau; Emsri Pongponratn
Journal:  Int J Clin Exp Pathol       Date:  2014-04-15

9.  Chemokine receptor CCR2 is not essential for the development of experimental cerebral malaria.

Authors:  Elodie Belnoue; Fabio T M Costa; Ana M Vigário; Tatiana Voza; Françoise Gonnet; Irène Landau; Nico Van Rooijen; Matthias Mack; William A Kuziel; Laurent Rénia
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

10.  Glatiramer acetate reduces the risk for experimental cerebral malaria: a pilot study.

Authors:  Peter Lackner; Andrea Part; Christoph Burger; Anelia Dietmann; Gregor Broessner; Raimund Helbok; Markus Reindl; Erich Schmutzhard; Ronny Beer
Journal:  Malar J       Date:  2009-02-27       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.